Contura International Contura International

Profile

Contura International's Profile

New £150,000 study explores how a pioneering new treatment for knee osteoarthritis could work in the NHS

A major new study to confirm the clinical effectiveness of a novel treatment for knee osteoarthritis in a UK setting…

Contura Orthopaedics Ltd joins the International Cartilage Regeneration & Joint Preservation Society as its newest industry partner

Contura Orthopaedics Ltd is delighted to join the International Cartilage Regeneration & Joint Preservation Society as its newest industry partner…
Contura International, 23&Beyond event

Contura International heralds a new era of innovation as hydrogel technology continues to expand globally

100s of employees, partners and shareholders associated with hydrogel technology pioneers Contura International have come together to celebrate the so-called…

New partnership sees Ireland's orthopaedic market bring innovative treatment to 100s of patients suffering with knee osteoarthritis

Contura Orthopaedics Ltd has announced an exciting new partnership with Hogan Healthcare, one of Ireland’s leading independent medical device distributors. Arthrosamid…
Contura International London HQ

PIONEERING TREATMENT FOR INCONTINENCE USED ACROSS THE NHS RECEIVES APPROVAL FROM THE FDA

Contura (headquartered in London) is pleased to announce official notification from the Federal Drug Administration (“FDA”) that the premarket approval…